Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564769 · ClinicalTrials.gov registry record · NA
Evaluation Study of SPOTme® Skin Cancer Screenings
A NA study, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- NA
- Development phase
- 431
- Enrollment target
NCT03564769 is a NA study that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 431 participants.
The verdict
NCT03564769, a NA study, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- NA
- Development phase
- 431 participants
- Enrollment target
Study Summary
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.
Interventions
- BEHAVIORAL Intervention Arm
- OTHER AAD SPOTmeⓇ skin cancer screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 431 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03564769
The ClinicalTrials.gov registry entry for NCT03564769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 431 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard School of Public Health (HSPH), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intervention Arm is the first listed.
NCT03564769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03564769 about?
NCT03564769 is a clinical study titled "Evaluation Study of SPOTme® Skin Cancer Screenings". This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.
What is the current status of trial NCT03564769?
This trial is currently completed. It is a NA study. The enrollment target is 431 participants. The study started on 2017-12-01. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT03564769?
The interventions under investigation include: Intervention Arm (BEHAVIORAL), AAD SPOTmeⓇ skin cancer screening (OTHER).
Who is sponsoring clinical trial NCT03564769?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.